LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Rice Bran Shows Potential as a Dietary Anticancer Agent

By LabMedica International staff writers
Posted on 20 Dec 2012
Print article
Rice bran is a source of potent anti-inflammatory and anticancer compounds and, due to its low production costs, is a candidate for development into a global dietary chemoprevention agent.

Researchers at Colorado State University (Fort Collins, USA) reviewed the current biomedical status of rice bran in a paper published in the September 2012 issue of the journal Advances in Nutrition.

They reported that the chemopreventive attributes of rice bran are due to the presence of bioactive phytochemicals such as ferulic acid, tricin, beta-sitosterol, gamma-oryzanol, tocotrienols/tocopherols, and phytic acid.

The researchers cited studies, which showed that the anticancer effects of rice bran's bioactive components were mediated through their ability to induce apoptosis, inhibit cell proliferation, and alter cell cycle progression in malignant cells. Rice bran's bioactive components protected against tissue damage through the scavenging of free radicals and the blocking of chronic inflammatory responses. These bioactive phytochemicals were shown to activate anticancer immune responses as well as affecting the colonic tumor microenvironment in favor of suppressing the development of colorectal cancer. This was accomplished through the modulation of gut microflora communities and the regulation of carcinogen-metabolizing enzymes.

“While I have been trained as a molecular toxicologist, I am excited about the opportunities to deliver bioactive, cancer fighting compounds with food, and this has led to my focus now primarily on the multiple drug-like characteristics of rice bran,” said senior author Dr. Elizabeth P. Ryan, assistant professor of environmental and radiological health sciences at Colorado State University. “There is a delicate balance of bioactive components in rice bran that together show anticancer activity including the ability to inhibit cell proliferation, alter cell cycle progression and initiate the programmed cell death known as apoptosis in malignant cells. We are working now to tease apart the ratios of these active molecules required for bioactivity and mechanisms. Previous attempts to isolate one or another compound have been largely unsuccessful and so it looks now as if rather than any one compound giving rice bran its chemopreventive powers, it is the synergistic activity of multiple components in the whole food that should be studied.”

“There are well over 100,000 varieties of rice in the world, many with their own unique mix of bioactive components, and so one major challenge is to discover the optimal composition for chemoprevention. Another challenge is ensuring that people consistently receive the required daily intake amount or "dose" needed to demonstrate these chemoprotective effects. That said, rice is an accessible, low-cost food in most places of the world, and so work with rice bran as a dietary chemopreventive agent has the potential to impact a significant portion of the world’s population,” said Dr. Ryan.

Related Links:
Colorado State University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more